Special features of non-melanoma skin cancer in Hong Kong Chinese patients: 10-year retrospective study.

OBJECTIVE To determine the incidence and clinical characteristics of non-melanoma skin cancer in Hong Kong Chinese patients. DESIGN Retrospective study. SETTING Social Hygiene Services, Hong Kong. PATIENTS Records of 528 Chinese patients with a histological diagnosis of non-melanoma skin cancer from 1990 to 1999 were reviewed. MAIN OUTCOME MEASURES Demographic data, site and clinical type of cancer, predisposing factors, history, recurrence, and the development of new skin cancers. RESULTS Non-melanoma skin cancer is uncommon but not rare among the Chinese population in Hong Kong. The incidence of newly diagnosed basal cell carcinoma in 1990 was 16.0 per 10,000 new skin case attendances and, in 1999, the incidence was 31.8 per 10,000 new skin case attendances. The corresponding figures for squamous cell carcinoma in 1990 and 1999 were 6.9 and 11.6 per 10,000 new skin case attendances. The incidence of basal cell carcinoma among the Hong Kong Chinese population in 1990 and 1999 was 0.32 and 0.92 per 100,000, respectively, whereas that of squamous cell carcinoma was 0.16 and 0.34 per 100,000, respectively. Demographic data and the site distribution of non-melanoma skin cancer were comparable to those reported in Caucasians living in North America and Europe, but different from those in Caucasians living in Australia and Hawaii. Pigmented basal cell carcinoma was the most common type of non-melanoma skin cancer (60.1%) in Chinese patients, in contrast with rodent ulceration in Caucasian. Multiple skin cancers, recurrence, and subsequent new skin cancers were less frequently observed than in studies of Caucasians. CONCLUSION When compared with reported findings in Caucasians, Chinese patients show differences in the clinical type and multiplicity of lesions, predisposing factors, recurrence, and subsequent new skin cancer rates for non-melanoma skin cancer. Pigmented basal cell carcinoma seems to be an important differential diagnosis with regard to pigmented lesions in the Chinese population.

[1]  A. Marghoob,et al.  Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma , 1993 .

[2]  L Naldi,et al.  Consensus workshop on the toxic effects of long-term PUVA therapy. , 1998, Archives of dermatology.

[3]  J. L. Stone,et al.  Basal cell carcinoma in Kauai, Hawaii: the highest documented incidence in the United States. , 1993, Journal of the American Academy of Dermatology.

[4]  H. Garrett,et al.  Pigmented basal-cell epithelioma: a comparison of its incidence and characteristics in the Latin-American and Anglo-American populations. , 1960, Archives of dermatology.

[5]  P Jensen,et al.  Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. , 1999, Journal of the American Academy of Dermatology.

[6]  C. la Vecchia,et al.  Descriptive epidemiology of skin cancer in the Swiss Canton of Vaud , 1988, International journal of cancer.

[7]  M. Weinstock.  Epidemiology of nonmelanoma skin cancer: clinical issues, definitions, and classification. , 1994, The Journal of investigative dermatology.

[8]  D I McLean,et al.  Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. , 1990, Journal of the American Academy of Dermatology.

[9]  A. Kopf,et al.  Multivariate risk score for recurrence of cutaneous basal cell carcinomas. , 1983, Archives of dermatology.

[10]  S. Strom,et al.  Epidemiology of nonmelanoma skin cancer. , 1997, Clinics in plastic surgery.

[11]  R. Marks,et al.  Skin cancer in a Queensland population. , 1988, Journal of the American Academy of Dermatology.

[12]  M A Weinstock,et al.  Nonmelanoma skin cancer in the United States: incidence. , 1994, Journal of the American Academy of Dermatology.

[13]  S. Tan,et al.  SKIN CANCERS AT TERTIARY REFERRAL SKIN HOSPITAL IN SINGAPORE , 1995, International journal of dermatology.

[14]  R. Stern,et al.  Nonmelanoma cancers of the skin. , 1992, The New England journal of medicine.

[15]  H. Shimizu,et al.  Clinical histopathological characteristics of basal cell carcinoma in Japanese patients. , 1996, Archives of dermatology.

[16]  D. Jones,et al.  Pigmented basal cell carcinoma: investigation of 70 cases. , 1992, Journal of the American Academy of Dermatology.

[17]  R. S. Padilla,et al.  Pigmented basal cell carcinoma in Hispanics. , 1996, Journal of the American Academy of Dermatology.

[18]  A. Mak,et al.  Audit of basal cell carcinoma in Princess Margaret Hospital, Hong Kong: usefulness of frozen section examination in surgical treatment. , 1995, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

[19]  R. Marks,et al.  Trends in non‐melanocytic skin cancer treated in Australia: The second national survey , 1993, International journal of cancer.

[20]  D. Czarnecki.  The prognosis of patients with basal and squamous cell carcinoma of the skin , 1998, International journal of dermatology.

[21]  S. Walton,et al.  The emerging epidemic of skin cancer , 1994, The British journal of dermatology.

[22]  RobinRussell Jones,et al.  OZONE DEPLETION AND CANCER RISK , 1987, The Lancet.

[23]  D. Czarnecki,et al.  The development of non-melanocytic skin cancers in people with a history of skin cancer. , 1994, Dermatology.

[24]  K. Knox,et al.  Recurrent squamous cell carcinoma of the skin , 1983, Cancer.

[25]  C. Chute,et al.  Basal cell carcinoma. A population-based incidence study in Rochester, Minnesota. , 1990, Journal of the American Academy of Dermatology.